Stock OSE OSE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris
Other stock markets
 11:35:28 2024-04-26 EDT 		5-day change 1st Jan Change
5.56 EUR -0.71% Intraday chart for OSE Immunotherapeutics +3.35% +29.91%
04-17 OSE: licensing agreement with AbbVie enters into force CF
04-17 OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie MT

Evolution of the average Target Price on OSE Immunotherapeutics

Price target over the last 5 years

History of analyst recommendation changes

887a4a90dd1.ylqpsRqK1O4tm9udZxrU8y8WAg04rlDSsJ0JF74TG4U.h2nTwH-_sLtc_KHOBlymyn0vQHlM6ze-gchOYfZdT9_9NeGFK82mhUrfuA~e7553bf77367eb9dcaa702a5a3edb66c

Analyst Recommendations on OSE Immunotherapeutics

OSE IMMUNOTHERAPEUTICS : Degroof Petercam reiterates buy recommendation CF
OSE IMMUNO : Oddo BHF confirms its recommendation CF
OSE IMMUNO : Invest Securities confirms its recommendation CF
OSE IMMUNO : Invest Securities confirms its recommendation CF
Ose Immuno: share price falls, broker lowers target CF
OSE IMMUNO : Invest Securities lowers its target CF
TODAY'S ANALYST RECOMMENDATIONS : Barclays, Ford, Microsoft, Oracle, Lloyds... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.56 EUR
Average target price
7.15 EUR
Spread / Average Target
+28.60%
High Price Target
7.3 EUR
Spread / Highest target
+31.29%
Low Price Target
7 EUR
Spread / Lowest Target
+25.90%

Consensus detail

Consensus revision (last 18 months)

Ratings for OSE Immunotherapeutics

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OSE Stock
  4. Consensus OSE Immunotherapeutics